Cargando…

Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma

Despite the rapid growing and aging of populations worldwide, our knowledge on hepatocellular carcinoma (HCC) is still age-standardized rather than age-specific, with only few studies exploring the topic from a genetic point of view. Here, we analyze clinical and genetic aspects of HCC in patients o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atyah, Manar, Yin, Yi-Rui, Zhou, Chen-Hao, Zhou, Qiang, Chen, Wan-Yong, Dong, Qiong-Zhu, Ren, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128442/ https://www.ncbi.nlm.nih.gov/pubmed/30125264 http://dx.doi.org/10.18632/aging.101531

Ejemplares similares

The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications
por: Ren, Ning, et al.
Publicado: (2017)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma
por: Zhou, Chenhao, et al.
Publicado: (2017)

Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients
por: Zhou, Qiang, et al.
Publicado: (2021)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Sun, Jialei, et al.
Publicado: (2019)

Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)

The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
por: Atyah, Manar, et al.
Publicado: (2022)

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism()
por: Zhou, Qiang, et al.
Publicado: (2022)

A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma
por: Zhou, Chenhao, et al.
Publicado: (2022)

The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection
por: Xue, Min, et al.
Publicado: (2020)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Characteristics of the cancer stem cell niche and therapeutic strategies
por: Ju, Feng, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Focus on Different Aspects of Management
por: Waly Raphael, Sene, et al.
Publicado: (2012)

Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma
por: Ling, Yi-Hong, et al.
Publicado: (2023)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Mechano-Signaling Aspects of Hepatocellular Carcinoma
por: Passi, Mehak, et al.
Publicado: (2021)

Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects
por: Yeh, Yao-Tsung, et al.
Publicado: (2013)

Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Hui, et al.
Publicado: (2022)

Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis
por: Xing, Tonghai, et al.
Publicado: (2018)

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
por: Carrilho, Flair Jose, et al.
Publicado: (2010)

Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients
por: Xu, Xin-Sen, et al.
Publicado: (2015)

Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo
por: Zhou, Lei, et al.
Publicado: (2016)

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
por: Xia, Shunjie, et al.
Publicado: (2020)

Clinical Aspects of Gut Microbiota in Hepatocellular Carcinoma Management
por: Xu, Jinghang, et al.
Publicado: (2021)

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737
por: Tang, Lei, et al.
Publicado: (2022)

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
por: Tang, Weiwei, et al.
Publicado: (2020)

Laparoscopic versus open left hemihepatectomy for hepatocellular carcinoma: a propensity score matching analysis
por: Yi, Yong, et al.
Publicado: (2020)

Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma
por: Weng, Jialei, et al.
Publicado: (2023)

Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis
por: Chen, Xiaolong, et al.
Publicado: (2021)

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2022)

Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma
por: Wu, Jin-Cai, et al.
Publicado: (2014)

Integrative bioinformatics analysis identifies ROBO1 as a potential therapeutic target modified by miR-218 in hepatocellular carcinoma
por: Wang, Junqing, et al.
Publicado: (2017)

Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
por: Tu, Thomas, et al.
Publicado: (2014)

Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2021)

The spatial distribution of immune cell subpopulations in hepatocellular carcinoma
por: Wang, Peng‐Cheng, et al.
Publicado: (2021)

Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m6dfjaq2obf0om9pmgq00gt9h9